Patents by Inventor Andrew Wei

Andrew Wei has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250071202
    Abstract: A transcript of a call between a client and agent can be provided in real-time or near real-time and used to present links to relevant knowledge documents to the agent during the call. The call transcript can be automatically summarized and stored after the call.
    Type: Application
    Filed: August 22, 2024
    Publication date: February 27, 2025
    Inventors: Dylan DAYA, Steven PHAN, Andrew WEI, Neha Sudhir HIMANE, Curtis RYAN, Domenic PAGNIELLO
  • Patent number: 11466023
    Abstract: A combination comprising a Mcl-1 inhibitor and a second anticancer agent, wherein the second anticancer agent is selected from anthracyclines, cytarabine and hypomethylating agents, and compositions and uses thereof.
    Type: Grant
    Filed: June 21, 2018
    Date of Patent: October 11, 2022
    Assignees: LES LABORATOIRES SERVIER, NOVARTIS AG
    Inventors: Andrew Wei, Donia Moujalled, Giovanna Pomilio, Olivier Geneste, Ana Leticia Maragno
  • Publication number: 20200392151
    Abstract: A combination comprising a Mcl-1 inhibitor and a second anticancer agent, wherein the second anticancer agent is selected from anthracyclines, cytarabine and hypomethylating agents, and compositions and uses thereof.
    Type: Application
    Filed: June 21, 2018
    Publication date: December 17, 2020
    Inventors: Andrew WEI, Donia MOUJALLED, Giovanna POMILIO, Olivier GENESTE, Ana Leticia MARAGNO
  • Publication number: 20190240225
    Abstract: A combination comprising a BCL-2 inhibitor and a MCL1 inhibitor, and compositions and uses thereof.
    Type: Application
    Filed: July 21, 2017
    Publication date: August 8, 2019
    Applicants: LES LABORATOIRES SERVIER, NOVARTIS AG
    Inventors: Andrew WEI, Donia MOUJALLED, Giovanna POMILIO, Ana Leticia MARAGNO, Olivier GENESTE, Audrey CLAPERON, Heiko MAACKE, Ensar HALILOVIC, Dale PORTER, Erick MORRIS, Youzhen WANG, Sneha SANGHAVI, Prakash MISTRY
  • Publication number: 20080027145
    Abstract: The present invention relates generally to therapeutic molecules useful for inducing apoptosis of particular cells such as, but not limited to, cancer cells and methods for generating and/or selecting same. The present invention further provides methods for inducing apoptosis of cells such as cancer cells and pharmaceutical compositions useful for same. The present invention further provides methods for generating or selecting therapeutic agents capable of inducing apoptosis of particular cells by the selective inhibition of pro-survival proteins. The present invention further provides a computational approach to therapeutic molecule design based on structure-binding characteristics.
    Type: Application
    Filed: February 3, 2005
    Publication date: January 31, 2008
    Inventors: David C. S. Huang, Peter M. Colman, Catherine L. Day, Jerry M. Adams, Lin Chen, Simon N. Willis, Andrew Wei, Brian J. Smith, Mark G. Hinds
  • Publication number: 20070266305
    Abstract: A method comprising enabling selection of interactivity control points of interest in media content; forwarding identification of at least one interactivity control point of interest to a wrapper generator; and attaching at least one script to the media content to monitor the at least one interactivity control point of interest when the media content is executed. The interactivity control points may include clickable points and mouse movement. The media content may include Flash media. The at least one script may be capable of monitoring all instances of consumer interaction with the interactivity control points occurring during media content playback. The method may also comprise generating configuration data for configuring the script to monitor only a portion of the instances of the consumer interaction with the interactivity control points occurring during media content playback.
    Type: Application
    Filed: May 10, 2006
    Publication date: November 15, 2007
    Inventors: David Cong, Richard Liu, Jim Miao, Tommy Zhao, Andrew Wei, Esther Poon
  • Publication number: 20070197430
    Abstract: Conformationally constrained peptides that mimic BH3-only proteins and their conjugation to antibodies and other cell targeting compounds, compositions containing the conjugates and their use in the regulation of cell death are disclosed. The conformationally constrained peptides are capable of binding to and neutralising pro-survival Bcl-2 proteins. Processes for preparing the conformationally constrained peptides conjugated to antibodies and other cell targeting compounds and use of the conjugates in the treatment and/or prophylaxis of diseases or conditions associated with deregulation of cell death are also disclosed.
    Type: Application
    Filed: June 24, 2005
    Publication date: August 23, 2007
    Inventors: Jonathan Baell, Andrew Wei, Denis Scanlon